Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor

In a new bioRxiv study, authors identified a isoform of ACE2 (designated as deltaACE2 or dACE2) receptor, shown to be induced in various human cell types.

23 Jul 2020

New article sheds light on challenges faced by vaccine developers

With the global pandemic still in full swing, scientists are working to develop a vaccine in record time. While everyone wants an effective vaccine, they don't all agree on how to get there and what "effective" really means.

23 Jul 2020

Disinfection of drinking water using UV light

While awaiting full access to their labs due to COVID-19 restrictions, scientists at the National Institute of Standards and Technology have taken this rare opportunity to report the technical details of pioneering research they conducted on the disinfection of drinking water using ultraviolet light.

23 Jul 2020

New collaboration brings over 20,000 onsite COVID-19 tests to Detroit’s residents

A partnership among Altimetrik, a Southfield-based fast-growing global business transformation company, the 501(c)(3) Vattikutti Foundation, Henry Ford Health System and the City of Detroit has provided more than 20,000 onsite COVID-19 tests to residents in 163 of Detroit's senior and congregate living facilities, as well as the city's first responders and essential workers.

23 Jul 2020

Mysterious enzyme inhibits inflammation in blood vessels, LJI study shows

Scrape your knee, and you'll see some red puffiness appear around the injury. This is inflammation, and it is driven by the immune system.

23 Jul 2020

Researchers assess the damage caused by microbubbles in brain injuries

Say there's a bomb attack on a military base. A few of the soldiers suffer concussions and other brain injuries. Could some of the injuries be caused by tiny bubbles that form and collapse within the skull during head trauma?

23 Jul 2020

NIH leaders create a framework to scale up testing technologies for COVID-19

In a paper in the New England Journal of Medicine, scientific leaders from the National Institutes of Health set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for underserved populations that have been disproportionally affected by the disease.

23 Jul 2020

Study shows antibodies drop sharply in first three months after mild COVID-19 cases

A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 -- the virus that causes the disease -- drop sharply over the first three months after infection, decreasing by roughly half every 73 days.

23 Jul 2020

For-profit status of LTC homes is associated with more cases of COVID-19 outbreaks, deaths

For-profit status is associated with the extent of an outbreak of coronavirus disease 2019 (COVID-19) in long-term care (LTC) homes and the number of resident deaths from COVID-19, but not the likelihood of an outbreak, which was related to the infection rate in the surrounding local public health unit and the total number of beds in the home, found new research published in CMAJ (Canadian Medical Association Journal).

23 Jul 2020

Findings could help design vaccines against coronavirus

Scientists investigating the evolution of the virus that causes Covid19 say that its mutation seems to be directed by human proteins that degrade it, but natural selection of the virus enables it to bounce back. The findings could help in the design of vaccines against the virus.

23 Jul 2020

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, today announced that the Clinical Trial Application for COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Singapore Health Sciences Authority.

22 Jul 2020

Report highlights the need to improve quality of care for high-risk veterans

Veterans who have served in the U.S. military since the 9/11 attacks have a high level of need for both substance use treatment and mental health care, yet many do not receive appropriate help for their co-occurring disorders, according to a new RAND Corporation report.

22 Jul 2020

Georgia State researchers receive NSF grant to develop coronavirus test tools

Georgia State University researchers have received a one-year, $200,000 rapid response grant from the National Science Foundation to develop a tool to detect the presence of SARS-CoV-2, the virus causing the COVID-19 pandemic.

22 Jul 2020

Malaria drug does not prevent infection of human lung cells with novel coronavirus

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

22 Jul 2020

Common hypertension drugs do not increase risk of severe, fatal COVID-19 infection

A new Northwestern Medicine study in mice found a widely used class of drugs to treat patients with hypertension, cardiovascular disease and diabetic kidney disease - many of whom are elderly -- does not increase the risk of developing a severe and potentially fatal COVID-19 infection, as previously feared.

22 Jul 2020

Researchers win grant to study why COVID-19 patients lose their sense of smell

Researchers at the University of Colorado Anschutz Medical Campus have won a grant to study why many infected with Covid-19 lose their sense of smell.

22 Jul 2020

Scientists want to know more about using UV light to fight COVID-19 spread

High up near the ceiling, in the dining room of his Seattle-area restaurant, Musa Firat recently installed a “killing zone” — a place where swaths of invisible electromagnetic energy penetrate the air, ready to disarm the coronavirus and other dangerous pathogens that drift upward in tiny, airborne particles.

22 Jul 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor

New article sheds light on challenges faced by vaccine developers

Disinfection of drinking water using UV light

New collaboration brings over 20,000 onsite COVID-19 tests to Detroit’s residents

Mysterious enzyme inhibits inflammation in blood vessels, LJI study shows

Researchers assess the damage caused by microbubbles in brain injuries

NIH leaders create a framework to scale up testing technologies for COVID-19

Study shows antibodies drop sharply in first three months after mild COVID-19 cases

For-profit status of LTC homes is associated with more cases of COVID-19 outbreaks, deaths

Findings could help design vaccines against coronavirus

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Report highlights the need to improve quality of care for high-risk veterans

Georgia State researchers receive NSF grant to develop coronavirus test tools

Malaria drug does not prevent infection of human lung cells with novel coronavirus

Common hypertension drugs do not increase risk of severe, fatal COVID-19 infection

Researchers win grant to study why COVID-19 patients lose their sense of smell

Scientists want to know more about using UV light to fight COVID-19 spread

Essential and in danger: Coronavirus sickens, even kills public health workers

New studies indicate the presence of cerebrovascular-neurological dysfunction in COVID-19 patients

Study shows chloroquine does not prevent SARS-CoV-2

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in